Compare DMRC & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DMRC | BDSX |
|---|---|---|
| Founded | 2008 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Precision Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.8M | 122.0M |
| IPO Year | 2008 | 2020 |
| Metric | DMRC | BDSX |
|---|---|---|
| Price | $4.69 | $14.87 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $10.00 | ★ $32.50 |
| AVG Volume (30 Days) | ★ 272.0K | 131.3K |
| Earning Date | 03-11-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.58 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $25,213,000.00 | ★ $88,499,000.00 |
| Revenue This Year | N/A | $25.26 |
| Revenue Next Year | N/A | $19.70 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 15.69 | ★ 24.08 |
| 52 Week Low | $4.07 | $0.25 |
| 52 Week High | $14.64 | $20.21 |
| Indicator | DMRC | BDSX |
|---|---|---|
| Relative Strength Index (RSI) | 41.20 | 48.80 |
| Support Level | $4.07 | $6.33 |
| Resistance Level | $7.10 | $20.21 |
| Average True Range (ATR) | 0.64 | 1.49 |
| MACD | -0.12 | -0.54 |
| Stochastic Oscillator | 12.64 | 8.41 |
Digimarc Corp is engaged in digital watermarking technologies. The Digimarc Illuminate platform is a distinctive software as a service (SaaS) cloud-based platform for digital connectivity that provides the tools for the application of digital watermarks and dynamic Quick Response (QR) codes, software (digital twins) that enables various systems and devices to interact with those data carriers and a centralized platform for capturing insights about digital interactions and automating activities based on that information. The company generates revenue through commercial and government applications of its technology. The company derives its revenue from software development services, subscriptions for products and related services, and licensing of patents.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.